These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8542406)
1. The effect of neurotrophin-5 on the growth and survival of nigral grafts in a rat model of Parkinson's disease. Haque NS; Hlavin ML; Fawcett J; Dunnett SB Gene Ther; 1994; 1 Suppl 1():S60. PubMed ID: 8542406 [No Abstract] [Full Text] [Related]
2. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease. Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602 [TBL] [Abstract][Full Text] [Related]
3. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results. Kirik D; Björklund A Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119 [No Abstract] [Full Text] [Related]
4. Pig xenografts to the immunocompetent rat brain: Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains. Robichon R; Jaafar A; Terqui M; Brachet P; Peschanski M Exp Neurol; 2005 Aug; 194(2):333-40. PubMed ID: 16022861 [TBL] [Abstract][Full Text] [Related]
5. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923 [TBL] [Abstract][Full Text] [Related]
7. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293 [TBL] [Abstract][Full Text] [Related]
8. Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Rozas G; Labandeira García JL Brain Res; 1997 Feb; 749(2):188-99. PubMed ID: 9138718 [TBL] [Abstract][Full Text] [Related]
9. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease]. Yang H; Zhang K; Cai W Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501 [TBL] [Abstract][Full Text] [Related]
10. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation. Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120 [TBL] [Abstract][Full Text] [Related]
11. Pleiotrophin promotes functional recovery after neural transplantation in rats. Hida H; Masuda T; Sato T; Kim TS; Misumi S; Nishino H Neuroreport; 2007 Jan; 18(2):179-83. PubMed ID: 17301686 [TBL] [Abstract][Full Text] [Related]
12. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease. Hahn M; Timmer M; Nikkhah G J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889 [TBL] [Abstract][Full Text] [Related]
13. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Galpern WR; Burns LH; Deacon TW; Dinsmore J; Isacson O Exp Neurol; 1996 Jul; 140(1):1-13. PubMed ID: 8682173 [TBL] [Abstract][Full Text] [Related]
14. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610 [TBL] [Abstract][Full Text] [Related]
15. [Transplantation of nigral and adrenal tissue into the striatum in rats--an experimental model for the surgical treatment of Parkinson disease]. Novaković B; Nagulić M; Nagulić I; Mrsulja ; Vujadinović M; Pavićević M Srp Arh Celok Lek; 1991; 119(7-8):179-81. PubMed ID: 1792572 [TBL] [Abstract][Full Text] [Related]
16. The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease. Haque NS; Hlavin ML; Fawcett JW; Dunnett SB Brain Res; 1996 Mar; 712(1):45-52. PubMed ID: 8705306 [TBL] [Abstract][Full Text] [Related]
17. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Yurek DM; Lu W; Hipkens S; Wiegand SJ Exp Neurol; 1996 Jan; 137(1):105-18. PubMed ID: 8566202 [TBL] [Abstract][Full Text] [Related]
18. Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model. Goren B; Kahveci N; Eyigor O; Alkan T; Korfali E; Ozluk K Surg Neurol; 2005; 64 Suppl 2():S33-41. PubMed ID: 16256839 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic graft-induced long-term recovery of complex sensorimotor behaviors in a rat model of Parkinson's disease. Nikkhah G; Rosenthal C; Falkenstein G; Samii M Zentralbl Neurochir; 1998; 59(2):97-103. PubMed ID: 9674098 [TBL] [Abstract][Full Text] [Related]
20. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts. Shinoda M; Hoffer BJ; Olson L J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]